Acheulean Biotech
Building the Future of Living Machines.
A biological engineering company developing biohybrid robotics. Systems that integrate living tissue with engineered soft materials to produce movement and force.
Machines powered by living tissue.
Where conventional robots rely on motors, gears, and hydraulics, biohybrid systems use living muscle as the actuator itself.
This opens a path toward machines that are softer, more efficient, and fundamentally more compatible with living systems than the rigid machines that came before them. Acheulean's work draws on tissue engineering, biomaterials, bioprinting, and optogenetic control — the same foundational tools now reshaping regenerative medicine and synthetic biology.
By engineering muscle tissue onto precisely designed soft scaffolds, and by controlling that tissue with light rather than wires, the company aims to build actuators that contract, bend, and move the way living muscle does — with an efficiency and gentleness that mechanical systems cannot match.
Machines built not from sensors and motors, but from living biology.
The sense of touch.
Develops the sensing and interface side, giving machines a biological sense of touch and returning that sensation to a human operator.
The power of motion.
Develops the actuation side, giving machines living tissue to move with — muscle engineered into motion.
One company teaches machines to feel. The other teaches them to move.
Four foundations of biological actuation.
Tissue Engineering
Growing and shaping living muscle tissue for use as an actuator.
Biomaterials
Soft, biocompatible scaffolds that living tissue can grow on and move.
Bioprinting
Precisely placing cells and materials into engineered geometries.
Optogenetic Control
Directing tissue with light rather than wires — control without hardware.
These are hard problems, and the science is early. Keeping engineered tissue alive and functional outside a body remains one of the central challenges of the field. Acheulean is built to work at exactly that frontier.
Oriented toward the long horizon.
The applications the company is working toward are deliberately long-range: soft medical devices that work with the body rather than against it; biohybrid implants that assist rather than replace; gentle actuation for delicate environments; and platforms for studying living tissue outside the body.